3-119365267-G-A
Variant names:
Variant summary
Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_020754.4(ARHGAP31):c.101-49G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00318 in 1,480,920 control chromosomes in the GnomAD database, including 124 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.015 ( 61 hom., cov: 33)
Exomes 𝑓: 0.0019 ( 63 hom. )
Consequence
ARHGAP31
NM_020754.4 intron
NM_020754.4 intron
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.137
Publications
1 publications found
Genes affected
ARHGAP31 (HGNC:29216): (Rho GTPase activating protein 31) This gene encodes a GTPase-activating protein (GAP). A variety of cellular processes are regulated by Rho GTPases which cycle between an inactive form bound to GDP and an active form bound to GTP. This cycling between inactive and active forms is regulated by guanine nucleotide exchange factors and GAPs. The encoded protein is a GAP shown to regulate two GTPases involved in protein trafficking and cell growth. [provided by RefSeq, Jul 2008]
ARHGAP31 Gene-Disease associations (from GenCC):
- Adams-Oliver syndrome 1Inheritance: AD Classification: STRONG Submitted by: G2P, Labcorp Genetics (formerly Invitae)
- Adams-Oliver syndromeInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.83).
BP6
Variant 3-119365267-G-A is Benign according to our data. Variant chr3-119365267-G-A is described in ClinVar as [Benign]. Clinvar id is 1183029.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAdExome4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.0529 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ARHGAP31 | NM_020754.4 | c.101-49G>A | intron_variant | Intron 1 of 11 | ENST00000264245.9 | NP_065805.2 | ||
ARHGAP31 | XM_006713714.4 | c.101-49G>A | intron_variant | Intron 1 of 11 | XP_006713777.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0146 AC: 2222AN: 152128Hom.: 61 Cov.: 33 show subpopulations
GnomAD3 genomes
AF:
AC:
2222
AN:
152128
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.00386 AC: 882AN: 228394 AF XY: 0.00306 show subpopulations
GnomAD2 exomes
AF:
AC:
882
AN:
228394
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00187 AC: 2482AN: 1328674Hom.: 63 Cov.: 19 AF XY: 0.00167 AC XY: 1115AN XY: 667582 show subpopulations
GnomAD4 exome
AF:
AC:
2482
AN:
1328674
Hom.:
Cov.:
19
AF XY:
AC XY:
1115
AN XY:
667582
show subpopulations
African (AFR)
AF:
AC:
1678
AN:
30432
American (AMR)
AF:
AC:
124
AN:
44010
Ashkenazi Jewish (ASJ)
AF:
AC:
23
AN:
25348
East Asian (EAS)
AF:
AC:
0
AN:
38254
South Asian (SAS)
AF:
AC:
19
AN:
82678
European-Finnish (FIN)
AF:
AC:
2
AN:
46386
Middle Eastern (MID)
AF:
AC:
26
AN:
5508
European-Non Finnish (NFE)
AF:
AC:
369
AN:
1000100
Other (OTH)
AF:
AC:
241
AN:
55958
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
123
245
368
490
613
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
GnomAD4 genome AF: 0.0146 AC: 2223AN: 152246Hom.: 61 Cov.: 33 AF XY: 0.0146 AC XY: 1084AN XY: 74430 show subpopulations
GnomAD4 genome
AF:
AC:
2223
AN:
152246
Hom.:
Cov.:
33
AF XY:
AC XY:
1084
AN XY:
74430
show subpopulations
African (AFR)
AF:
AC:
2085
AN:
41526
American (AMR)
AF:
AC:
87
AN:
15294
Ashkenazi Jewish (ASJ)
AF:
AC:
5
AN:
3468
East Asian (EAS)
AF:
AC:
0
AN:
5190
South Asian (SAS)
AF:
AC:
1
AN:
4822
European-Finnish (FIN)
AF:
AC:
0
AN:
10604
Middle Eastern (MID)
AF:
AC:
2
AN:
294
European-Non Finnish (NFE)
AF:
AC:
14
AN:
68026
Other (OTH)
AF:
AC:
29
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.505
Heterozygous variant carriers
0
107
214
321
428
535
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
14
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
Feb 16, 2020
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.